Investor News
Presentation: RBP-6000 Data Presented in Late-Breaking Research Oral Session at CPDD 79th Annual Scientific Meeting on June 21, 2017
Click here to view the presentation.
Read moreRBP-6000 Data Presented in Late-Breaking Research Oral Session at CPDD 79th Annual Scientific Meeting
To view the presentation deck click here. Indivior PLC Presents Results from the Phase 3…
Read moreRBP-6000 Investor Event Announcement
Indivior to Host Investor Event on RBP-6000 on June 29th at 12:00 Noon EDT US…
Read moreWebcast Event: Shaun Thaxter, CEO of Indivior PLC presented at the Jefferies Global Healthcare Conference on June 6, 2017
Click here to view the presentation webcast. The presentation can also be downloaded as a…
Read moreIndivior Submits New Drug Application to U.S. FDA for RBP-6000 Buprenorphine Monthly Depot
Indivior Submits New Drug Application to U.S. FDA for RBP-6000 Buprenorphine Monthly Depot A Potential…
Read moreWebcast Event: Shaun Thaxter, CEO of Indivior PLC presented at the Jefferies Global Healthcare Conference on June 6, 2017
Click here to view the presentation webcast. The presentation can also be downloaded as a…
Read moreIndivior’s Shaun Thaxter to present at the Jefferies Global Healthcare Conference on June 6th
Slough, UK, May 23, 2017 – Indivior PLC (LON: INDV) today announced that Shaun Thaxter, CEO,…
Read more2017 Annual General Meeting
2017 Annual General Meeting Indivior PLC’s 2017 Annual General Meeting was held on Wednesday, May 17,…
Read moreWebcast Event: Q1 2017 Financial Results
Click here for the archived recording of the conference call.
Read more